Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Statin Holiday in Maintenance Dialysis Patients
NCT03663049Phase 4Unknown
- Sponsor
- Loyola University Chicago
- Start
- Aug 2018
- Primary completion
- May 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ulinastatin in cardiovascular disease (CVD) (2 arms), sponsored by Loyola University Chicago. Primary endpoint: Quality of Life at 12 weeks. Status: unknown.
02
Drugs
ulinastatin
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT03663049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03663049.